DIVERSIFY WEALTH MANAGEMENT, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 2030780
SANDY, UT
Position in TEVA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,864,668
+$1,633,090 QoQ
Shares Held
61,908
+734.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DIVERSIFY WEALTH MANAGEMENT, LLC holds $12,592,869 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
71,616 | $8,465,727 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
31,566 | $1,870,916 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
61,908 | $1,864,668 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,597 | $210,388 | |
| 5 | HLN |
Haleon plc
|
16,091 | $161,070 | |
| 6 | BTAI |
BioXcel Therapeutics, Inc.
|
15,000 | $20,100 |
All Filings in TEVA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,864,668 | 61,908 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $231,578 | 7,420 | Shares | Sole | 2026-02-03 | |
| 2024-12-31 | $942,408 | 42,759 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $626,915 | 34,790 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||